医薬品リファレンス
Tislelizumab
Tislelizumab is a medicine in the class oncology. It is used for gastric cancer.
- 薬効分類: Oncology
- 効能・効果: gastric cancer
最終更新日 出典: EMA SmPC
医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。
このページの臨床コンテンツは英語でのみ提供されています。
要点
- 薬効分類
- Oncology
- ATCコード
- L01FF09
- 一般的な剤形
- 注射剤
- 一般的な規格
- 10 mg/ml
- 既知の相互作用
- 6 (中等度: 5 · 軽度: 1)
- 商品名
- 2
- 国・市場
- 2
何に使われるか
作用のしくみ
Humanised IgG4 variant monoclonal antibody against PD-1 that binds the extracellular domain of human PD-1 and competitively blocks binding of PD-L1 and PD-L2. This inhibits PD-1-mediated negative signalling and enhances T-cell functional activity in in vitro assays.
成人の通常用量（添付文書の要約）
Monotherapy: 200 mg once every 3 weeks or 400 mg once every 6 weeks, intravenous infusion; treat until disease progression or unacceptable toxicity
妊娠と授乳
- 妊娠
- Unsafe No data in pregnant women; can cause foetal harm based on its mechanism of action. Do not use during pregnancy unless the woman's clinical condition requires treatment.
- 授乳
- Unsafe Unknown whether excreted in human milk; women should not breast-feed during treatment and for at least 4 months after the last dose.
報告されている副作用
- Anaemia
- Aspartate aminotransferase increased
- Fatigue
- Alanine aminotransferase increased
- Neutropenia (with chemotherapy)
- Thrombocytopenia (with chemotherapy)
禁忌
- Hypersensitivity to the active substance or to any excipient.
注意が必要な方
- Immune-related adverse reactions, including fatal cases, can affect any organ system and may occur after the last dose; evaluate and withhold, with corticosteroids as needed.
- Immune-related pneumonitis, including fatal cases; monitor for signs and symptoms.
- Immune-related hepatitis; perform liver function tests at baseline and periodically.
妊娠中または授乳中であること、腎臓や肝臓の病気、アレルギー、ほかに使用しているすべての薬やサプリメントについて、薬剤師または医師にお伝えください。
主な相互作用 (6)
- Amoxicillin + Tislelizumab Moderate
- Amoxicillin-clavulanic acid + Tislelizumab Moderate
- Piperacillin + Tislelizumab Moderate
- Piperacillin-tazobactam + Tislelizumab Moderate
- Prednisone + Tislelizumab Moderate
- Penicillin g + Tislelizumab Minor
Pro+会員向け
ページ全体を見る
アカウントを作成してPro+トライアルを始めると、Tislelizumabの完全なモノグラフ（用量、妊娠・授乳、副作用、警告、すべての相互作用）を表示できます。
- Dosing by age, kidney and liver function, and further dose lines
- Renal and hepatic dose adjustments
- Dosing in older adults
- How to give it
- Pharmacokinetics
- Patient counselling points
WebでPro+を14日間無料でお試し。カード登録不要。
同じ分類のほかの薬剤
よくある質問
What is Tislelizumab used for?
Tislelizumab is a medicine in the class oncology. It is used for Gastric cancer, Lung cancer, Non-small cell lung cancer.
What side effects have been reported with Tislelizumab?
Anaemia, Aspartate aminotransferase increased, Fatigue, Alanine aminotransferase increased, Neutropenia (with chemotherapy), Thrombocytopenia (with chemotherapy).
Can Tislelizumab be taken in pregnancy or while breastfeeding?
Pregnancy: Unsafe. No data in pregnant women; can cause foetal harm based on its mechanism of action. Do not use during pregnancy unless the woman's clinical condition requires treatment. Breastfeeding: Unsafe. Unknown whether excreted in human milk; women should not breast-feed during treatment and for at least 4 months after the last dose.
What does Tislelizumab interact with?
MediHelp lists 6 known interactions for Tislelizumab. Moderate: 5 · Minor: 1. The most serious include Amoxicillin, Amoxicillin-clavulanic acid, Piperacillin.
完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで
MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。
